Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Co-Diagnostics, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
CODX
Nasdaq
3840
co-dx.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Co-Diagnostics, Inc.
Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025
- Dec 9th, 2025 7:00 am
Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India
- Dec 8th, 2025 10:36 am
CoDiagnostics (CODX) Upgraded to Buy: Here's What You Should Know
- Dec 2nd, 2025 10:00 am
Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health
- Nov 20th, 2025 7:00 am
Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA
- Nov 18th, 2025 7:00 am
Co-Diagnostics Inc (CODX) Q3 2025 Earnings Call Highlights: Strategic Ventures and Financial ...
- Nov 13th, 2025 10:02 pm
Co-Diagnostics (CODX) Q3 2025 Earnings Transcript
- Nov 13th, 2025 3:29 pm
Co-Diagnostics, Inc. (CODX) Reports Q3 Loss, Misses Revenue Estimates
- Nov 13th, 2025 3:15 pm
Co-Diagnostics Reports Third Quarter 2025 Financial Results
- Nov 13th, 2025 2:01 pm
Utah Governor Cox and BioUtah Recognize Co-Diagnostics Following Recent JV Announcement in Kingdom of Saudi Arabia
- Nov 12th, 2025 7:00 am
Progyny (PGNY) Q3 Earnings and Revenues Beat Estimates
- Nov 6th, 2025 3:20 pm
Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd
- Nov 5th, 2025 7:00 am
CareDx (CDNA) Surpasses Q3 Earnings and Revenue Estimates
- Nov 4th, 2025 4:15 pm
Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform
- Nov 3rd, 2025 7:00 am
Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast
- Oct 31st, 2025 7:00 am
Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia
- Oct 30th, 2025 11:57 am
Sector Update: Health Care Stocks Fall Late Afternoon
- Oct 29th, 2025 1:54 pm
Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
- Oct 29th, 2025 10:51 am
Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
- Oct 28th, 2025 7:33 am
Trending tickers: Amazon, Qualcomm, Tesla, Co-Diagnostics and Qorvo
- Oct 28th, 2025 3:13 am
Scroll